CER-001: Clinical Trials

1 trial of CER-001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow CER-001: new trials by email Literature Review of CER-001 trials Research Report on CER-001

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases
CER-001, Placebo - Familial Hypoalphalipoproteinemia
Phase 3TerminatedCerenis Therapeutics, SA302015-12-012025-07-22

Conditions studied

Hypoalphalipoproteinemias (1)

Sponsors

Cerenis Therapeutics, SA (1)

Countries

Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Erik SG Stroes, MD PhD (1)